Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzo Biochem Inc (NYSE:ENZ)

6.67
Delayed Data
As of Dec 02
 +0.06 / +0.91%
Today’s Change
4.00
Today|||52-Week Range
7.20
+48.22%
Year-to-Date

Today’s Trading

Previous close6.61
Today’s open6.64
Day’s range6.45 - 6.73
Volume411,386
Average volume (3 months)166,644
Market cap$308.7M
Dividend yield--
Data as of 4:02pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+15.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+5.30%
P/E ratio6.9
Price/Sales3.16
Price/Book3.45

Competitors

 Today’s
change
Today’s
% change
RDNTRadNet Inc+0.10+1.65%
NVTAInvitae Corp+0.16+2.36%
PTIProteostasis Therape...+0.20+1.94%
CCMConcord Medical Serv...+0.01+0.22%
Data as of 4:02pm ET, 12/02/2016

Financials

Next reporting dateDecember 9, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$102.8M
Annual profit (last year)$45.3M
Net profit margin44.06%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive Officer &
Secretary
Elazar Rabbani
President, CFO, Treasurer &
Class II Director
Barry W. Weiner
Corporate headquarters
New York, New York

Forecasts


Search for Jobs